• / Free eNewsletters & Magazine
  • / My Account
Home>Drug Companies

Drug Companies

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Veeva Vault Selected by inVentiv Health Clinical to Empower Sponsors with Cloud-based eTMF Clinical Trial Platform

    Veeva Vault Selected by inVentiv Health Clinical to Empower Sponsors with Cloud-based eTMF Clinical Trial Platform

  2. 3PEA International and Haemonetics Partner to Integrate PaySign Connect with Haemonetics’ Donor Management System

    3PEA International and Haemonetics Partner to Integrate PaySign Connect with Haemonetics’ Donor Management System

  3. SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Auxilium Pharmaceuticals , Inc. And Encourages Investors To Contact The Firm For Additional Information

    SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Auxilium Pharmaceuticals , Inc. And Encourages Investors To Contact The Firm For Additional Information

  4. Research and Markets: Global Potential Analysis of Ebola Drug and Vaccines Market 2014-2020: Leading Companies are Tekmira, BioCryst, Serepata Therapeutics, NewLink Genetics and Mapp ...

    Research and Markets: Global Potential Analysis of Ebola Drug and Vaccines Market 2014-2020: Leading Companies are Tekmira, BioCryst, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical

  5. Five Things You Should Know About U.S. Small-Caps

    NPS Pharmaceuticals NPSP raised $50 million Monday through the sale of its Preotact royalty stream to Drug Royalty Corporation. We're maintaining our fair value estimate as we believe the exchange was fair but not favorable to shareholders. The proceeds will satisfy part of a $190 million ...

  6. Developed Asia Pacific: Regional Economic Review – Q3 2014

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

  7. Fighting Ebola though investing: one firm's approach

    Fighting Ebola though investing: one firm's approach

  8. Research and Markets: Competitor Analysis: Ebola Virus Vaccines and Therapeutics Report 2014 Featuring Over 30 Institutions

    Research and Markets: Competitor Analysis: Ebola Virus Vaccines and Therapeutics Report 2014 Featuring Over 30 Institutions

  9. Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting

    Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting

  10. Research and Markets: Global Ebola Virus Vaccine Market & Pipeline Insight Report 2014 - Analysis of 26 Clinical Trials & 15 in Preclinical Phase

    Research and Markets: Global Ebola Virus Vaccine Market & Pipeline Insight Report 2014 - Analysis of 26 Clinical Trials & 15 in Preclinical Phase

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.